Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study

• প্রধান লেখক: Mohammad Zamani (লেখক), Hossein Poustchi (লেখক), Zahra Mohammadi (লেখক), Sahar Dalvand (লেখক), Maryam Sharafkhah (লেখক), Seyed Abbas Motevalian (লেখক), Saeid Eslami (লেখক), Amir Emami (লেখক), Mohammad Hossein Somi (লেখক), Jamshid Yazdani-Charati (লেখক), Nader Saki (লেখক), Manoochehr Karami (লেখক), Farid Najafi (লেখক), Iraj Mohebbi (লেখক), Nasrollah Veisi (লেখক), Ahmad Hormati (লেখক), Farhad Pourfarzi (লেখক), Reza Ghadimi (লেখক), Alireza Ansari-Moghaddam (লেখক), Hamid Sharifi (লেখক), Gholamreza Roshandel (লেখক), Fariborz Mansour-Ghanaei (লেখক), Farahnaz Joukar (লেখক), Amaneh Shayanrad (লেখক), Sareh Eghtesad (লেখক), Ahmadreza Niavarani (লেখক), Alireza Delavari (লেখক), Soudeh Kaveh (লেখক), Akbar Feizesani (লেখক), Melineh Markarian (লেখক), Fatemeh Shafighian (লেখক), Alireza Sadjadi (লেখক), Maryam Darvishian (লেখক), Reza Malekzadeh (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: BMC, 2022-05-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Abstract Background The first large serosurvey in Iran found a SARS-CoV-2 antibody seroprevalence of 17.1% among the general population in the first wave of the epidemic by April, 2020. The purpose of the current study was to assess the seroprevalence of COVID-19 infection among Iranian general popu...